Focal nodular hyperplasia of the liver: Diffusion and perfusion MRI characteristics

Magnetic Resonance Imaging

Volumn 31, Issue 1, 2013, Pages 10-16

  Donati, Francescamaria ^a   Boraschi, Piero ^a   Gigoni, Roberto ^a   Salemi, Simonetta ^a   Falaschi, Fabio ^a   Bartolozzi, Carlo ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Diffusion weighted MR imaging; Focal nodular hyperplasia; Liver; Liver MR; Perfusion weighted MR imaging

Indexed keywords

GADOBENATE DIMEGLUMINE; SODIUM CHLORIDE;

ADULT; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; LIVER FOCAL NODULAR HYPERPLASIA; LIVER PARENCHYMA; MALE; MAXIMAL SLOPE; MAXIMUM ENHANCEMENT PERCENTAGE; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; TIME SIGNAL INTENSITY CURVE; TIME TO PEAK ENHANCEMENT;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84870371554     PISSN: 0730725X     EISSN: 18735894     Source Type: Journal    
DOI: 10.1016/j.mri.2012.06.031     Document Type: Article

References (21)

1. Hussain S.M., Terkivatan T., Zondervan P.E., Lanjouw E., de Rave S., Ijzermans J.N., et al. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis. Radiographics 2004, 24:3-17.
2. Grazioli L., Morana G., Federle M.P., Brancatelli G., Testoni M., Kirchin M.A., et al. Focal nodular hyperplasia: morphological and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001, 221:731-739.
3. Grazioli L., Morana G., Kirchin M.A., Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005, 236:166-177.
4. Chandarana H., Taouli B. Diffusion and perfusion imaging of the liver. Eur J Radiol 2010, 76:348-358.
5. Lavini C., De Jonge M.C., van de Sande M.G., Tak P.P., Nederveen A.J., Maas M. Pixel-by-pixel analysis of DCE MRI curve patterns and an illustration of its application to the imaging of the musculoskeletal system. Magn Reson Imaging 2007, 25:604-612.
6. Wang L., Van den Bos I.C., Hussain S.M., Pattynama P.M., Vogel M.W., Krestin G.P. Post-processing of dynamic gadolinium-enhanced magnetic resonance imaging exams of the liver: explanation and potential clinical applications for color-coded qualitative and quantitative analysis. Acta Radiol 2008, 49:6-18.
7. Sijens P.E. Parametric exploration of the liver by magnetic resonance methods. Eur Radiol 2009, 19:2594-2607.
8. Seale M.K., Catalano O.A., Saini S., Hahn P.F., Sahani D.V. Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 2009, 29:1725-1748.
9. Vandecaveye V., De Keyzer F., Verslype C., Op de Beeck K., Komuta M., Topal B., et al. Diffusion-weighted MRI provides additional value to conventional dynamic contrast-enhanced MRI for detection of hepatocellular carcinoma. Eur Radiol 2009, 19:2456-2466.
10. Taouli B., Vilgrain V., Dumont E., Daire J.L., Fan B., Menu Y. Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 2003, 226:71-78.
11. Yoshikawa T., Kawamitsu H., Mitchell D.G., Ohno Y., Ku Y., Seo Y., et al. ADC measurement of abdominal organs and lesions using parallel imaging technique. AJR Am J Roentgenol 2006, 187:1521-1530.
12. Goshima S., Kanematsu M., Kondo H., Yokoyama R., Kajita K., Tsuge Y., et al. Diffusion-weighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatic lesions. J Magn Reson Imaging 2008, 28:691-697.
13. Vossen J.A., Buijs M., Liapi E., Eng J., Bluemke D.A., Kamel I.R. Receiver operating characteristic analysis of diffusion-weighted magnetic resonance imaging in differentiating hepatic hemangioma from other hypervascular liver lesions. J Comput Assist Tomogr (JCAT) 2008, 32:750-756.
14. Kele P.G., van der Jagt E. Diffusion weighted imaging in the liver. World J Gastroenterol 2010, 16:1567-1576.
15. Bruegel M., Holzapfel K., Gaa J., Woertler K., Waldt S., Kiefer B., et al. Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echoplanar MR imaging technique. Eur Radiol 2008, 18:477-485.
16. International Working Party Terminology of nodular hepatocellular lesions. Hepatology 1995, 22:983-993.
17. Pandharipande P.V., Krinsky G.A., Rusine K., Lee V.S. Perfusion imaging of the liver: current challenges and future goals. Radiology 2005, 234:661-673.
18. Thng C.H., Koh T.S., Collins D.J., Koh D.M. Perfusion magnetic resonance imaging of the liver. World J Gastroenterol 2010, 16:1598-1609.
19. Koh T.S., Thng C.H., Lee P.S., Hartono S., Rumpel H., Goh B.C., et al. Hepatic metastases: in vivo assessment of perfusion parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment tracer kinetics model. Radiology 2008, 249:307-320.
20. Miyazaki K., Collins D.J., Walker-Samuel S., Taylor J.N., Padhani A.R., Leach M.O., et al. Quantitative mapping of hepatic perfusion index using MR imaging: a potential reproducible tool for assessing tumour response to treatment with the antiangiogenic compound BIBF 1120, a potent triple angiokinase inhibitor. Eur Radiol 2008, 18:1414-1421.
21. Materne R., Smith A.M., Peeters F., Dehoux J.P., Keyeux A., Horsmans Y., et al. Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 2002, 47:135-142.